• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压在血液透析相关性动脉粥样硬化中的作用。

The role of hypertension in hemodialysis-associated atherosclerosis.

作者信息

Vincenti F, Amend W J, Abele J, Feduska N J, Salvatierra O

出版信息

Am J Med. 1980 Mar;68(3):363-9. doi: 10.1016/0002-9343(80)90104-7.

DOI:10.1016/0002-9343(80)90104-7
PMID:6987872
Abstract

Atherosclerosis in 50 nondiabetic patients undergoing hemodialysis was assessed at the time of renal transplantation by intraoperative examination and histologic evaluation of the iliac vasculature. Patients were grouped accordingly: minimal (group 1), moderate (group 2) or severe (group 3) atherosclerosis. Sixty-two per cent of the patients had atherosclerosis, half of them with severe involvement. No sex differences were noted. There was a significant correlation between the patient's age and the degree of atherosclerosis (p less than 0.02). Thirty-five per cent of the patients under 30 years of age had atherosclerosis whereas similarly studied nonuremic control subjects had no atherosclerosis. Metabolic and lipid abnormalities, and duration of hemodialysis did not correlate with degree of atherosclerosis. Hypertension was present in 90 per cent of the patients in groups 2 and 3. When patients between the ages of 25 and 40 years were selected, atherosclerosis was present only in previously hypertensive patients (p less than 0.02). Atherosclerosis may not be accelerated by hemodialysis and may be prevented by more stringent control of hypertension in uremia.

摘要

在肾移植时,通过术中检查和对髂血管的组织学评估,对50例接受血液透析的非糖尿病患者的动脉粥样硬化情况进行了评估。患者据此分为:轻度(第1组)、中度(第2组)或重度(第3组)动脉粥样硬化。62%的患者患有动脉粥样硬化,其中一半为重度病变。未发现性别差异。患者年龄与动脉粥样硬化程度之间存在显著相关性(p<0.02)。30岁以下的患者中,35%患有动脉粥样硬化,而经过类似研究的非尿毒症对照受试者未患动脉粥样硬化。代谢和脂质异常以及血液透析时间与动脉粥样硬化程度无关。第2组和第3组中90%的患者患有高血压。当选择年龄在25至40岁之间的患者时,动脉粥样硬化仅出现在既往有高血压的患者中(p<0.02)。血液透析可能不会加速动脉粥样硬化,通过更严格地控制尿毒症患者的高血压,可能预防动脉粥样硬化。

相似文献

1
The role of hypertension in hemodialysis-associated atherosclerosis.高血压在血液透析相关性动脉粥样硬化中的作用。
Am J Med. 1980 Mar;68(3):363-9. doi: 10.1016/0002-9343(80)90104-7.
2
Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.尿毒症患者、血液透析患者及肾移植受者的闭塞性动脉疾病。一项关于动脉疾病发病率及动脉粥样硬化发病机制中相关危险因素患病率的研究。
Q J Med. 1977 Apr;46(182):197-214.
3
Atherosclerosis in uremia: a longitudinal study.尿毒症中的动脉粥样硬化:一项纵向研究。
Am J Clin Nutr. 1980 Jul;33(7):1493-500. doi: 10.1093/ajcn/33.7.1493.
4
Study on the atherosclerosis mechanism in chronic hemodialysis.慢性血液透析中动脉粥样硬化机制的研究
Jpn Circ J. 1987 Jun;51(6):631-41. doi: 10.1253/jcj.51.631.
5
Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients.吸烟、血压和血清白蛋白是透析患者颈动脉粥样硬化的主要决定因素。CREED研究人员。透析患者心血管风险扩展评估。
J Nephrol. 1999 Jul-Aug;12(4):256-60.
6
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
7
Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: fact or fiction?
Lancet. 1980 Feb 9;1(8163):276-8. doi: 10.1016/s0140-6736(80)90777-1.
8
Atherosclerosis in patients with end-stage renal failure prior to initiation of hemodialysis.终末期肾衰竭患者在开始血液透析前的动脉粥样硬化。
Ren Fail. 2003 Mar;25(2):247-54. doi: 10.1081/jdi-120018725.
9
[Evaluation of atherosclerosis progression in patients treated repeatedly with hemodialysis].
Przegl Lek. 2002;59(8):606-10.
10
Atherosclerosis risk factors related to hemodialysis duration and erythropoietin therapy.与血液透析时长及促红细胞生成素治疗相关的动脉粥样硬化危险因素
Clin Chem Lab Med. 2001 Jun;39(6):484-6. doi: 10.1515/CCLM.2001.079.

引用本文的文献

1
Current understanding of optimal blood pressure goals in dialysis patients.
Curr Hypertens Rep. 2006 Oct;8(5):413-9. doi: 10.1007/s11906-006-0088-6.
2
Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure.单核细胞组织因子及黏附分子的表达:与慢性肾衰竭患者冠状动脉疾病加速的关联
Heart. 1999 Feb;81(2):134-40. doi: 10.1136/hrt.81.2.134.
3
Osteoporosis and atherosclerosis in chronic renal failure.慢性肾衰竭中的骨质疏松与动脉粥样硬化
Osteoporos Int. 1997;7 Suppl 3:S188-92. doi: 10.1007/BF03194370.
4
Disturbances of lipid metabolism in children with chronic renal failure.慢性肾功能衰竭患儿的脂质代谢紊乱
Pediatr Nephrol. 1993 Dec;7(6):749-57. doi: 10.1007/BF01213345.
5
[Reno-cardiac interactions in kidney failure (author's transl)].肾衰竭中的肾心相互作用(作者译)
Klin Wochenschr. 1980 Oct 1;58(19):1043-50. doi: 10.1007/BF01476875.
6
Role of the kidney in hormone metabolism and its implications in clinical medicine.肾脏在激素代谢中的作用及其在临床医学中的意义。
Klin Wochenschr. 1980 Oct 1;58(19):1005-12. doi: 10.1007/BF01476870.
7
Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effects.在接受慢性血液透析的患者中使用苯扎贝特进行降脂治疗:药代动力学及疗效
Klin Wochenschr. 1986 Oct 1;64(19):910-6. doi: 10.1007/BF01728614.
8
Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure.慢性肾衰竭患者的血浆草酸盐浓度与继发性草酸中毒
J Clin Pathol. 1988 Oct;41(10):1107-13. doi: 10.1136/jcp.41.10.1107.